课题基金 / 基金详情

项目摘要

项目成果

Joseph G. Sklar的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):结核分枝杆菌感染仍然是一种严重的全球健康危机,需要新的治疗药物和预防策略。鉴于这些要求,发现这种生物毒力所需的生物学过程对于确定潜在的药物靶标至关重要。其中大量的蛋白质参与了细胞膜的生物发生和维持。我们实验室以前的工作表明,RIP1(Rv2869c)膜内酶是小鼠生长和存活所必需的,也是维持分枝杆菌细胞膜所必需的。RIP1是膜内金属蛋白水解酶S2P家族的成员,它能在跨膜区内切割底物。这些蛋白水解级联反应通过下游转录网络参与了细胞间环境刺激的转导。初步数据表明,RIP1蛋白水解酶活性受铁限制激活,并控制多条下游途径。本申请描述了一种逻辑方法,在该方法中,结合传统的遗传学和生化技术,可以识别下游转录靶标对小鼠RIP1依赖的衰减的相对贡献。此外,我们将确定RIP1依赖的低铁信号转导的分子机制。
英文摘要
DESCRIPTION (provided by applicant): M. tuberculosis infection remains a severe global health crisis that demands new therapeutic agents and preventative strategies. In light of these requirements, the discovery of biological processes required for the virulence of this organism have been paramount for the identification of potential drug targets. A large number of these proteins have been implicated in cell envelope biogenesis and maintenance. Previous work in our laboratory has shown that the Rip1 (Rv2869c) intramembrane protease is required for growth and persistence in mice and is necessary for maintenance of the cell envelope of mycobacteria. Rip1 is a member of the Site two protease (S2P) family of intramembrane metalloproteases which cleave substrates within their transmembrane domains. These proteolytic cascades have been implicated in the transduction of environmental stimuli between cellular compartments via downstream transcriptional networks. Preliminary data show that Rip1 protease activity is activated by iron limitation and controls multiple downstream pathways. This application describes a logical approach in which a combination of conventional genetics and biochemical techniques allow for the identification of the relative contribution of the downstream transcriptional targets to Rip1 dependent attenuation in the mouse. Furthermore, we will determine the molecular mechanism responsible for Rip1 dependent low iron signaling.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulated Intramembrane Proteolysis in Mycobacterium Tuberculosis
Regulated Intramembrane Proteolysis in Mycobacterium Tuberculosis
海外基金